BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Humalog (Insulin Lispro) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Humalog (Insulin Lispro)\, from ClinicalT
 rials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06532461-320@assetmemo.bio
DTSTAMP:20261121T005605Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Humalog (Insulin Lispro): Phase na readout est. (NCT06532461)
DESCRIPTION:Humalog (Insulin Lispro)\, phase na\, Type 1 Diabetes.\nStudy: 
 A Trial of Three- and Seven-days Insulin Infusions Set\nEstimated primary 
 completion: 31 December 2026. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/insulin-lispro#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT06532461
URL:https://assetmemo.bio/drug/insulin-lispro#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06251635-320@assetmemo.bio
DTSTAMP:20261121T005605Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Humalog (Insulin Lispro): Phase na readout est. (NCT06251635)
DESCRIPTION:Humalog (Insulin Lispro)\, phase na\, Type 2 Diabetes.\nStudy: 
 Effects of Antipsychotics on Brain Insulin Action in Females\nEstimated pr
 imary completion: 31 December 2026. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/insulin-lispro#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06251635
URL:https://assetmemo.bio/drug/insulin-lispro#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06945406-320@assetmemo.bio
DTSTAMP:20261121T005605Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Humalog (Insulin Lispro): Phase 1 readout est. (NCT06945406)
DESCRIPTION:Humalog (Insulin Lispro)\, phase 1\, Type 2 Diabetes.\nStudy: A
  Study of LY4057996 in Healthy Participants and Participants With Type 1 a
 nd Type 2 Diabetes\nEstimated primary completion: July 2027. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/insulin-lispro#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT06945406
URL:https://assetmemo.bio/drug/insulin-lispro#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
